The North America Catheters Market is experiencing robust growth driven by technological advancements and rising chronic disease prevalence. The market size was valued at USD 7,900 Million in 2025 and is projected to reach USD 15,800 Million by 2035, growing at a CAGR of 7.2% from 2024 to 2035. Key players are focusing on innovation and strategic mergers to strengthen their market presence.
The economic impact of tariffs on "North America Catheters Market".
Market Growth Drivers
Rising Prevalence of Chronic Diseases: The increasing incidence of cardiovascular diseases, diabetes, and chronic kidney disorders in the North American region is a major driver for catheter demand. According to Medtronic, the growing geriatric population and changing lifestyle habits have led to a surge in catheterization procedures for diagnostics and treatments, such as angioplasty and dialysis. Hospitals and healthcare providers are preferring advanced and minimally invasive catheter technologies to reduce recovery times and hospital stays, which further propels market growth.
Innovations in Catheter Technologies: Industry leaders such as Boston Scientific are investing in the development of technologically advanced catheters, including antimicrobial and drug-eluting catheters. These innovations help in reducing device-related infections and improving procedural efficacy. For instance, Boston Scientific’s next-gen drug-coated balloon catheters, aimed at enhancing vascular intervention outcomes, have received regulatory approvals and wide adoption in the US, boosting the market’s growth trajectory.
Market Trends
Shift Towards Home Healthcare and Telemedicine: The trend of at-home patient care and telemedicine has accelerated following the COVID-19 pandemic. Companies like Becton Dickinson have launched portable and user-friendly catheter products, facilitating home treatments especially for urological and diabetes patients. This shift reduces hospital dependency and creates new avenues for catheter applications, aligning with the current healthcare infrastructure transformation.
Sustainability and Biocompatibility Focus: Increasing demand for eco-friendly and biocompatible materials is shaping product development in the catheter market. Leading firms such as Teleflex are introducing catheters made from biodegradable polymers to minimize environmental impact and reduce patient adverse reactions. This trend responds to stringent regulatory standards and growing patient awareness about device safety and environmental concerns.
Market Opportunities
Expansion in Ambulatory Surgical Centers: The proliferation of ambulatory surgical centers (ASCs) across North America presents significant opportunities for market players. Companies like Abbott Laboratories are targeting ASCs with specialized catheter solutions that offer quick setups and minimal downtime, capturing new customer segments.
Penetration of Digital and Smart Catheters: Adoption of smart catheters with sensors for continuous health monitoring is an emerging opportunity. Medline Industries is exploring digital catheters integrated with IoT capabilities, enabling remote diagnostics and personalized treatments in chronic care management.
North America Catheters Market Revenue (USD Million), 2020-2035
The chart presents a consistently upward revenue trend for the North America Catheters Market from 2020 to 2035. In 2020, revenue stood at USD 5,300 Million, rising steadily to USD 7,900 Million by 2025, supported by expanding procedural volumes and innovation. The market is projected to reach USD 15,800 Million by 2035 driven by increasing adoption of minimally invasive procedures and growing preference for advanced catheter types across healthcare settings. The CAGR of 7.2% highlights long-term growth potential fostered by sustained R&D, supportive regulatory policies, and evolving patient care models.
North America Catheters Market by Regions Share (%), 2025
The pie chart for 2025 reveals the United States as the dominant regional market, capturing 77% of the total market share, owing to advanced healthcare infrastructure, rising surgical procedures, and strong adoption of new technologies. Canada follows with a 16% share, supported by increasing healthcare investments and chronic illness management programs. Mexico holds a 5% share, reflecting its growing medical devices sector. The remaining 2% is distributed among smaller regions and dependencies, indicating limited but emerging opportunities outside the US and Canada.
Recent Developments in North America Catheters Market
In March 2024, Medtronic announced the commercial launch of its next-generation Reveal LINQ catheters in the US, designed with advanced continuous monitoring and wireless connectivity features. These catheters are said to enhance remote diagnostics and enable seamless data integration with electronic health records, reducing the need for repeat procedures and improving care outcomes.
Boston Scientific secured FDA clearance in April 2024 for its LUX-D XT drug-coated balloon catheter. This product is engineered for peripheral arterial disease interventions, with enhanced drug delivery and minimized procedural time. The company emphasized that the LUX-D XT’s success is rooted in improved patient safety and expanded therapeutic indications, positioning Boston Scientific for competitive growth.
In May 2024, Teleflex completed the acquisition of a Canadian catheter startup specializing in biodegradable urological catheters. The deal is aimed at accelerating Teleflex’s entry into the eco-friendly devices segment and meeting rising demand for sustainable, patient-friendly medical disposables in North America. Teleflex plans to expand manufacturing capacity in the US and Canada following the acquisition.
Press Releases